Attending Physician, Division of Endocrinology and Metabolism, Department of Internal medicine, CGMH
學歷
Taipei Medical University, Taipei, Taiwan, M.D.
經歷
Fellowship, Division of Endocrinology and Metabolism, CGMH
Residency, Department of Internal Medicine, CGMH
學會與認證
Board of The Diabetes Association of the Republic of China (Taiwan)
Board of The Endocrine Society of the Republic of China (Taiwan)
論文及期刊發表
Survival and death causes in thyroid cancer in Taiwan: a nationwide case-control cohort study. Cancers (Basel). 2021;13:3955. Lu YL, Lin SF (co-first authors), Wu MH, Lee YY, Lee PW, Chang SH, Huang YT*.
Efficacy and Biomarker Analysis of Adavosertib in Differentiated Thyroid Cancer. Cancers. 2021; 13:3487. Lu YL, Wu MH, Lee YY, Chou TC, Wong RJ, Lin SF*.
Efficacy of adavosertib therapy against anaplastic thyroid cancer. Endocr Relat Cancer 2021;28:311-324. Lu YL, Huang YT, Wu MH, Chou TC, J Wong R, Lin SF*.
Primary lung cancer with radioiodine avidity: A thyroid cancer cohort study. World J Clin Cases. 2021;9:71-80 Yu-Ling Lu, Szu-Tah Chen, Tsung-Ying Ho, Wen-Hui Chan, Richard J Wong, Chuen Hsueh, Shu-Fu Lin*.